Kriya Therapeutics

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• DCDaniel ChenExecutive Officer
• KEKatherine EadeExecutive Officer
• BFBrian FurmanskiExecutive Officer
• RGRyan GallagherDirector
• TGTrit GargDirector
• CHCurt HerbertsExecutive Officer
• RJRoger JeffsDirector
• DJDana JohnsonExecutive Officer
• ILIlise LombardoExecutive Officer
• KMKeith ManchesterDirector
• JMJames MomtazeeDirector
• IOIlan OrenDirector
• BPBritt PettyExecutive Officer
• ARAkshay RaiDirector
• SRSaira RamasastryDirector
• SRShankar RamaswamyDirector · Executive Officer
• NRNeera RavindranExecutive Officer
• CSC.R. SincockDirector
• MSMichele StoneExecutive Officer
• NVNeelaksh VarshneyDirector

• 04 Jun 2026Complement Pathway Inhibitor Fusions And Methods Of Using The Sameapplication
• 18 Sept 2025Insulin And Glucokinase Gene Therapy Compositions And Its Use For Treating Diabetesapplication
• 13 Mar 2025Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic ANTI-IGF-1R Antibodies And Methods Of Using The Sameapplication
• 20 Feb 2025Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancerapplication
• 28 Nov 2024Chimeric Modified Ion Channels And Uses Thereof For Treatment Of Trigeminal Nerve Disordersapplication
• 27 Aug 2024Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancergranted
• 02 May 2024Viral Vector Constructs Incorporating Dna For Inhibiting Toll Like Receptors And Methods Of Using The Sameapplication
• 21 Mar 2024Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-tnf Antibodies And Methods Of Using The Sameapplication
• —Periocular Delivery Of Aav Vectors For Treating Ophthalmic Pathologiesapplication
• —Complement Pathway Inhibitor Fusions And Methods Of Using The Sameapplication
• —Chimeric Modified Ion Channels And Uses Thereof For Treatment Of Trigeminal Nerve Disordersapplication
• —Riboswitches For Regulating Gene Expression And Therapeutic Methods Of Using The Sameapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.